Share On Social!
Did you know that Latinos comprise less than 7.6% of clinical trial participants?
This means that researchers have less chances to develop new cancer treatments for this population, which suffers a heavy burden of certain cancers, obesity, and mental health issues.
Join us and use #SaludTues on Jan. 21, 2020, to tweet about how to increase Latino participation in clinical trials to prevent health disparities, in celebration of the quickly approaching Advancing the Science of Cancer in Latinos conference:
- WHAT: #SaludTuesTweetchat: Engaging Latinos in Clinical Trials
- DATE/TIME: 1-2 p.m. EST (Noon-1 p.m. CST), Tuesday, January 21, 2020
- WHERE: On Twitter with hashtag #SaludTues
- HOST: @SaludAmerica
- CO-HOSTS: FDA Minority Health & Health Equity (@FDAHealthEquity)
We’ll open the floor to valuable information such as:
- The importance of clinical trials for Latinos;
- Barriers and enablers to clinical trial participation; and
- Strategies to increase Hispanic/Latino minority enrollment;
Be sure to use the hashtag #SaludTues to follow the conversation on Twitter, and share stories and resources to boost minority clinical trial participation.
“Most of today’s best cancer treatments are based on what we learned from past clinical trials,” said Dr. Amelie G. Ramirez, leader of the Salud America! and director of the Institute for Health Promotion Research at UT Health San Antonio. “The more Latinos join clinical trials, the faster we can find better cancer treatments and prevention options and increase survival rates.”
Click here to learn about the Salud America! #SaludTues tweetchats, see upcoming and past tweetchats, and see how you can get involved.
Explore More:Clinical Trials, Healthcare Access
By The Numbers
Expected rise in Latino cancer cases in coming years